Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

S Mirzaei, MK Mahabady, A Zabolian, A Abbaspour… - Life Sciences, 2021 - Elsevier
Glioblastoma multiforme (GBM) is one of the worst brain tumors arising from glial cells,
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …

A review of the current status of siRNA nanomedicines in the treatment of cancer

P Resnier, T Montier, V Mathieu, JP Benoit, C Passirani - Biomaterials, 2013 - Elsevier
RNA interference currently offers new opportunities for gene therapy by the specific
extinction of targeted gene (s) in cancer diseases. However, the main challenge for nucleic …

Advances in porous silicon–based nanomaterials for diagnostic and therapeutic applications

T Tieu, M Alba, R Elnathan… - Advanced …, 2019 - Wiley Online Library
This review provides a perspective on porous silicon (pSi)–based nanomaterials including
nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy …

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting

NT Huynh, E Roger, N Lautram, JP Benoît… - …, 2010 - Taylor & Francis
Research in designing and engineering long-circulating nanoparticles, so-called
'stealth'nanoparticles, has been attracting increasing interest as a new platform for targeted …

Engineering nanocarriers for siRNA delivery

SJ Tan, P Kiatwuthinon, YH Roh, JS Kahn, D Luo - Small, 2011 - Wiley Online Library
The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy
for the treatment of diseases. Nevertheless, despite promising results from experimental …

Delivery of synthetic mRNAs for tissue regeneration

H Steinle, J Weber, S Stoppelkamp… - Advanced drug delivery …, 2021 - Elsevier
In recent years, nucleic acid-based therapeutics have gained increasing importance as
novel treatment options for disease prevention and treatment. Synthetic messenger RNAs …

Small interfering RNA from the lab discovery to patients' recovery

M Caillaud, M El Madani… - Journal of Controlled …, 2020 - Elsevier
In 1998, the RNA interference discovery by Fire and Mello revolutionized the scientific and
therapeutic world. They showed that small double-stranded RNAs, the siRNAs, were …

Delivery systems and local administration routes for therapeutic siRNA

FTMC Vicentini, LN Borgheti-Cardoso, LV Depieri… - Pharmaceutical …, 2013 - Springer
With the increasing number of studies proposing new and optimal delivery strategies for the
efficacious silencing of gene-related diseases by the local administration of siRNAs, the …

Development of RNAi technology for targeted therapy—a track of siRNA based agents to RNAi therapeutics

Y Zhou, C Zhang, W Liang - Journal of Controlled Release, 2014 - Elsevier
RNA interference (RNAi) was intensively studied in the past decades due to its potential in
therapy of diseases. The target specificity and universal treatment spectrum endowed siRNA …

Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: where are we now?

M Berger, A Lechanteur, B Evrard, G Piel - International Journal of …, 2021 - Elsevier
Over the past two decades, RNA interference has become an extensively studied
mechanism to silence gene and treat diseases including cancer. siRNA appears as a …